Expert Speaker Faculty

Discover which expert speakers and KOLs are presenting at the 9th Liquid Biopsy for Precision Oncology Summit.

Anneleen Daemen headshot

Anneleen Daemen

Executive Director - Translational Medicine & Head Of Bioinformatics

ORIC Pharmaceuticals

Anthoula Lazaris headshot

Anthoula Lazaris

Scientific Director

RI-MUHC Liver Disease Biobank

Brian Haynes

Chief Scientific Officer & Head of Bioinformatics, Molecular & Diagnostics Division

Bio-Techne Corporation

Carolina Reduzzi

Assistant Professor - Director, Cristofanilli Circulating Tumor Cells Laboratory

Weill Cornell Imaging

Chris Conn Headshot

Chris Conn

Director, Clinical Biomarkers & Diagnostics, Global Diagnostics Strategy Lead

Amgen

Cynthia Sandoval Headshot

Cynthia Sandoval, PhD

Senior Director, Clinical Biomarker Development

Eli Lilly

David Weingeist Headshot

David Weingeist

Scientific Director, Oncology Diagnostics Leader

Johnson & Johnson Innovative Medicine

David Westenberg Headshot

David Westenberg

Sr. Research Analyst

Piper Sandler

Deepa Parthasarathy Headshot

Deepa Parthasarathy

Director, Biomarker Operations

Repare Therapeutics

Dr. Paul Hofman, MD, PhD

Professor of Pathology

Pillar Biosciences

Erin Newburn

Senior Director, Field Applications Scientist

LabCorp

Fatima Khaiser Headshot

Fatima Khaiser

Associate Director - Regulatory Affairs Device & Companion Diagnostics

Abbvie

Greg Opiteck Headshot

Gregory J Opiteck

Head, Precision & Translational Medicine

Affini-T Therapeutics

Holger Neecke

Chief Executive Officer

Tethis SpA

Hua Gong Headshot

Hua Gong

Senior Vice President & Global Head, Translational Medicine & Clinical Biomarker

Zai Lab

Hugh Wang Headshot

Hugh Wang

Director, Bioinformatics

Summit Therapeutics

Jane Anthony

Manager - CDx

Abbvie

Jean-Francois Martini

Executive Director - Biomarker Clinical Assay & Technology Group head

Pfizer

Jeff Gregg

Vice President Medical Affairs, Biofidelity - Professor of Pathology & Laboratory Medicine

University of Nevada School of Medicine

Joe McDermott Headshot

Joe McDermott

Bioinformatics Lead

Lantern Pharma

Jonathan Baden Headshot

John Baden

Executive Director, Head of Solid Tumour Oncology Diagnostics

Bristol Myers Squibb

Lauren Leiman Headshot

Laura Leiman

Executive Director

BLOODPAC

Lauren Houghtalin

Director, TSS Disease State

BioIVT

Lisa Boersma Headshot

Lisa Boersma

Associate Director, Precision Medicine & Companion Diagnostics

Regeneron

Marielana Mata Headshot

Marielena Mata

Senior Director - Clinical Biomarkers

Vividion Therapeutics

Matthew Pink

Vice President - Business Development

Biodesix (Moderator)

Mini Manchanda Headshot

Mini Manchanda

Director, Clinical Biomarkers & Companion Diagnostics

Kura Oncology

Olivier Harismendy Headshot

Olivier Harismendy

Vice President - Translational Data Sciences

Zentalis Pharmaceuticals

Paul Krzyzanowski Headshot

Paul Krzyzanowski

Medical Director

Johnson & Johnson Innovative Medicine

Peter Krein Headshot

Peter Krein

Senior Vice President, Precision Medicine

Boundless Bio

Peter Teriete Headshot

Peter Teriete

Co-Founder

IDEAYA Biosciences

Qian Shi Headshot

Qian Shi

Professor of Biostatistics and Oncology

Mayo Clinic

Rajiv Raja

Executive Director - Precision Medicine Oncology

GlaxoSmithKline

Robert Feeny Headshot

Robert Feeney

Director Account Solutions, Personalized & Precision Medicine

Novartis

Sarah Shagan Headshot

Sarah Shagan

Clinical Biomarker Lead

Genentech

Stephen Huang Headshot

Stephen Huang

Executive Director - Clinical Biomarkers & Companion Diagnostics

Avenzo Therapeutics

Valerie Mbella Headshot

Valerie Mbella

Director, Global Regulatory Affairs

Johnson & Johnson Innovative Medicine

Veerendra Munugalavadla Headshot

Veerendra Munugalavadla

Senior Director & Team Lead, Translational Medicine, Hematology R&D

AstraZeneca

“I'm thrilled to attend this liquid biopsy meeting, where the potential to transform cancer patient care and advance our field is truly within reach. This gathering offers an invaluable opportunity to explore the latest innovations, connect with leaders dedicated to pioneering solutions, and pave the way for more precise, personalized approaches to cancer treatment that could change countless lives”

Anneleen Daemen, Executive Director – Translational Medicine, ORIC Pharmaceuticals

EVENT GUIDE
REGISTER
PARTNER